Search research articles
Contact Us
Filters
Showing results (181-190 of 232) with videos related to
Page
of 24
Sort By:
Science (New York, N.Y.)
|
April 2, 2021
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
Evan W Weber, Kevin R Parker, Elena Sotillo, et al.
Nature Medicine
|
November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J Fry, Nirali N Shah, Rimas J Orentas, et al.
Cancer Cell
|
January 26, 2024
Inosine induces stemness features in CAR-T cells and enhances potency
Dorota D Klysz, Carley Fowler, Meena Malipatlolla, et al.
Research Square
|
November 21, 2023
FOXO1 is a master regulator of CAR T memory programming
Alexander Doan, Katherine P Mueller, Andy Chen, et al.
Cancer Research
|
December 2, 2024
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression
Caren Yu-Ju Wu, Yiyun Chen, Ya-Jui Lin, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
Inosine Induces Stemness Features in CAR T cells and Enhances Potency
Dorota D Klysz, Carley Fowler, Meena Malipatlolla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Blood Cancer Journal
|
April 4, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy
Masooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen, et al.
Eclinicalmedicine
|
November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns
Valentin Barsan, Yimei Li, Snehit Prabhu, et al.
Cancer Discovery
|
January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL
Yi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 232) with videos related to
Sort By:
Page
of 24
Science (New York, N.Y.)
|
April 2, 2021
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
Evan W Weber, Kevin R Parker, Elena Sotillo, et al.
Nature Medicine
|
November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J Fry, Nirali N Shah, Rimas J Orentas, et al.
Cancer Cell
|
January 26, 2024
Inosine induces stemness features in CAR-T cells and enhances potency
Dorota D Klysz, Carley Fowler, Meena Malipatlolla, et al.
Research Square
|
November 21, 2023
FOXO1 is a master regulator of CAR T memory programming
Alexander Doan, Katherine P Mueller, Andy Chen, et al.
Cancer Research
|
December 2, 2024
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression
Caren Yu-Ju Wu, Yiyun Chen, Ya-Jui Lin, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
Inosine Induces Stemness Features in CAR T cells and Enhances Potency
Dorota D Klysz, Carley Fowler, Meena Malipatlolla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Blood Cancer Journal
|
April 4, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy
Masooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen, et al.
Eclinicalmedicine
|
November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns
Valentin Barsan, Yimei Li, Snehit Prabhu, et al.
Cancer Discovery
|
January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL
Yi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Page
of 24